ROSEDAY GOLD 10 (Aspirin (75mg) + Rosuvastatin (10mg) + Clopidogrel (75mg))

ROSEDAY GOLD 10 represents a tri-action formulation aimed at the thorough and proactive management of patients who are at a significant risk of experiencing severe cardiovascular incidents such as heart attacks or strokes, as well as those undergoing procedures like angioplasty and stenting. This medication addresses fundamental contributors to cardiovascular conditions, notably elevated cholesterol levels and the formation of blood clots. It is primarily indicated for secondary prevention, which focuses on patients with existing cardiovascular issues to avert further complications, and in some instances for high-risk primary prevention to guard against initial events in individuals with notable risk factors. The formulation effectively lowers “bad” LDL cholesterol levels, minimizes inflammation, and inhibits clot formation, thereby offering extensive and varied defense for the heart and vascular system. The efficacy of ROSEDAY GOLD 10 results from the harmonious interplay of its three active components: Rosuvastatin, an HMG-CoA reductase inhibitor that significantly reduces LDL cholesterol and triglycerides while enhancing HDL cholesterol; Aspirin, which works as an antiplatelet agent to diminish platelet aggregation, thereby preventing blood clot formation; and Clopidogrel, another antiplatelet that operates through a unique pathway to further inhibit clot formation. Together, these ingredients create a synergistic effect that enhances cardiovascular protection and improves outcomes for at-risk patients, particularly after cardiac procedures.